×
Acasti Pharma Price to Free Cash Flow Ratio 2014-2024 | ACST
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Acasti Pharma price to free cash flow ratio from 2014 to 2024. Price to free cash flow ratio can be defined as
View More
Acasti Pharma Price to Free Cash Flow Ratio 2014-2024 | ACST
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Acasti Pharma price to free cash flow ratio from 2014 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$20.1B
Dr Reddy's Laboratories (RDY)
$13.1B
BridgeBio Pharma (BBIO)
$5B
Bausch Health Cos (BHC)
$3B
Amphastar Pharmaceuticals (AMPH)
$2.4B
Supernus Pharmaceuticals (SUPN)
$1.8B
Taysha Gene Therapies (TSHA)
$449M
Personalis (PSNL)
$315M
Assembly Biosciences (ASMB)
$117M
Sol-Gel Technologies (SLGL)
$20M
Evoke Pharma (EVOK)
$4M
Teligent (TLGT)
$0M